Gene therapie for cartilage repair;Gentherapie von knorpelgewebe

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 140, Issue 2, 2002, Pages 153-159

  Pelinkovic, Dalip ^a   Horas, U ^a   Engelhard, M ^a   Lee, J Y ^a   Huard, J ^a   Fu, F H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Arthritis; Cartilage; Gene therapy; Muscle derived cells; Stem cells

Indexed keywords

ARTICLE; ARTICULAR CARTILAGE; CHONDROPATHY; GENE THERAPY; HUMAN; NONHUMAN; TISSUE ENGINEERING; WOUND HEALING;

ARTHRITIS, RHEUMATOID; CHONDROCYTES; GENE THERAPY; HUMANS; OSTEOARTHRITIS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 0036265099     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-31533     Document Type: Article

References (57)

1. Assessment of donor cell and matrix survival in fresh articular cartilage allografts in a goat model
2. Preliminary observations of chondral abrasion in a canine model
3. Preliminary results with abrasion arthroplasty in the osteoarthritic knee
4. Homotransplantation of isolated epiphyseal and articular cartilage chondrocytes into joint surfaces of rabbits
5. Spongialization: A new treatment for diseased patellae
6. Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model
7. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation
8. Rabbit articular cartilage defects treated with autologous cultured chondrocytes
9. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation
10. Evidence of inappropriate application of autologous cartilage transplantation therapy in an uncontrolled environment [(GENERIC) Ref Type: Magazine Article]
11. Knorpelknochen-transplantation versus autologer knorpeltransplantation
12. The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. An experimental investigation in the rabbit
13. Neochondrogenesis in free intraarticular periosteal autografts in an immobilized and paralyzed limb. An experimental investigation in the rabbit
14. Repair of sheep articular cartilage defects with a rabbit costal perichondrial graft
15. Articular cartilage transplantation. Clinical results in the knee
16. Fresh osteochondral allografts for treatment of articular defects in osteochondritis dissecans of the lateral femoral condyle in adults
17. Fresh osteochondral allografts for post-traumatic osteochondral defects of the knee
18. Resurfacing the knee with fresh osteochondral allograft
19. Transforming growth factor beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures
20. Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes
21. Insulin-like growth factors I and II
22. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines
23. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy
24. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint
25. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta
26. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo
27. Possible orthopaedic applications of gene therapy
28. Lipofection: A highly effizient, lipid-mediated DNA-transfection procedure
29. Efficient lipid-mediated gene transfer to articular chondrocytes
30. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
31. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes
32. Ex vivo gene delivery using an adenovirus vector in treatment for cartilage defects
33. Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study
34. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation
35. New use of a three-dimensional pellet culture system for human intervertebral disc cells: Initial characterization and potential use for tissue engineering
36. Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: Implications for the clinical management of intervertebral disc disorders
37. Potential applications of gene therapy to the treatment of intervertebral disc disorders
38. In vitro transfer von genen in spinale gewebe
39. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
40. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
41. Genetic enhancement of matrix synthesis by articular chondrocytes: Comparison of different growth factor genes in the presence and absence of interleukin-1
42. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist
43. Gene delivery to human chondrocytes by an adeno associated virus vector
44. Genetherapy for tissue repair: Approaches and prospects
45. Gene therapy and future of cartilage repair
46. A method of resurfacing osteoarthritic knee joints
47. Muscle-based gene therapy and tissue engineering
48. Osteoprogenitor cells in skeletal muscle
49. Human myoblast transplantation: Preliminary results of 4 cases
50. Development of approaches to improve the healing following muscle contusion
51. Development of approaches to improve cell survival in myoblast transfer therapy
52. Myoblast-mediated gene transfer to the joint
53. Tissue engineering und gentherapie des bewegungsapparates mit muskelzellen
54. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
55. The fate of individual myoblasts after transplantation into muscles of DMD patients
56. Isolation of human myoblasts with the fluorescence-activated cell sorter
57. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy